Dr. Reddys Laboratories Ltd.

Dr. Reddy’s Laboratories has launched Metaxalone Tablets, USP 800 mg, a therapeutic equivalent generic version of Skelaxin (metaxalone) Tablets, approved by the U.S. Food and Drug Administration (USFDA).

The Skelaxin brand and generic had U.S. sales of approximately $139 million MAT for the most recent twelve months ending in July 2017 according to IMS Health. The company’s Metaxalone Tablets, USP 800 mg are available in the bottle count size of 100. Skelaxin is a trademark of King Pharmaceuticals Research and Development, Inc.

Dr. Reddy’s Laboratories is a multinational pharmaceutical company based in Hyderabad, Telangana in India. It manufactures and markets a wide range of pharmaceuticals in India and overseas.